Redcare Pharmacy NV
F:RDC

Watchlist Manager
Redcare Pharmacy NV Logo
Redcare Pharmacy NV
F:RDC
Watchlist
Price: 65.6 EUR 0.15% Market Closed
Market Cap: 1.2B EUR

Wall Street
Price Targets

RDC Price Targets Summary
Redcare Pharmacy NV

Wall Street analysts forecast RDC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RDC is 150.1 EUR with a low forecast of 76.06 EUR and a high forecast of 228.67 EUR.

Lowest
Price Target
76.06 EUR
16% Upside
Average
Price Target
150.1 EUR
129% Upside
Highest
Price Target
228.67 EUR
249% Upside
Redcare Pharmacy NV Competitors:
Price Targets
3549
Kusuri No Aoki Holdings Co Ltd
16% Upside
3391
Tsuruha Holdings Inc
13% Downside
MEDPLUS
MedPlus Health Services Ltd
35% Upside
3141
Welcia Holdings Co Ltd
16% Downside
RADL3
Raia Drogasil SA
12% Upside
9627
AIN Holdings Inc
13% Upside
3349
Cosmos Pharmaceutical Corp
24% Upside
PNVL3
Dimed SA Distribuidora de Medicamentos
10% Upside

Revenue
Forecast

Revenue Estimate
Redcare Pharmacy NV

For the last 8 years the compound annual growth rate for Redcare Pharmacy NV's revenue is 38%. The projected CAGR for the next 4 years is 19%.

38%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Redcare Pharmacy NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat

Net Income
Forecast

Net Income Estimate
Redcare Pharmacy NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RDC's stock price target?
Price Target
150.1 EUR

According to Wall Street analysts, the average 1-year price target for RDC is 150.1 EUR with a low forecast of 76.06 EUR and a high forecast of 228.67 EUR.

What is Redcare Pharmacy NV's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Redcare Pharmacy NV's revenue is 38%. The projected CAGR for the next 4 years is 19%.

Back to Top